SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
View ORCID ProfileSebastian Havervall, August Jernbom Falk, Jonas Klingström, Henry Ng, Nina Greilert-Norin, Lena Gabrielsson, Ann-Christin Salomonsson, Eva Isaksson, Ann-Sofie Rudberg, Cecilia Hellström, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Wanda Christ, Mikaela Olausson, My Hedhammar, Hanna Tegel, Sara Mangsbo, Mia Phillipson, Anna Månberg, Sophia Hober, Peter Nilsson, Charlotte Thålin
doi: https://doi.org/10.1101/2021.01.03.21249162
Sebastian Havervall
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
MDAugust Jernbom Falk
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScJonas Klingström
3Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
4Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden
PhDHenry Ng
5Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden
MMScNina Greilert-Norin
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
RNLena Gabrielsson
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
RNAnn-Christin Salomonsson
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
BScEva Isaksson
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
RNAnn-Sofie Rudberg
8Department of Neurology, Danderyd Hospital, Stockholm, Sweden
MDCecilia Hellström
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScEni Andersson
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScJennie Olofsson
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScLovisa Skoglund
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScJamil Yousef
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
MScElisa Pin
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDWanda Christ
3Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
MScMikaela Olausson
4Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden
MScMy Hedhammar
6Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
PhDHanna Tegel
6Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
PhDSara Mangsbo
7Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
PhDMia Phillipson
5Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden
PhDAnna Månberg
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDSophia Hober
6Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
PhDPeter Nilsson
2Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDCharlotte Thålin
1Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
MD, PhDData Availability
The data referred to in the manuscript is available upon reasonable request
Posted January 04, 2021.
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Sebastian Havervall, August Jernbom Falk, Jonas Klingström, Henry Ng, Nina Greilert-Norin, Lena Gabrielsson, Ann-Christin Salomonsson, Eva Isaksson, Ann-Sofie Rudberg, Cecilia Hellström, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Wanda Christ, Mikaela Olausson, My Hedhammar, Hanna Tegel, Sara Mangsbo, Mia Phillipson, Anna Månberg, Sophia Hober, Peter Nilsson, Charlotte Thålin
medRxiv 2021.01.03.21249162; doi: https://doi.org/10.1101/2021.01.03.21249162
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Sebastian Havervall, August Jernbom Falk, Jonas Klingström, Henry Ng, Nina Greilert-Norin, Lena Gabrielsson, Ann-Christin Salomonsson, Eva Isaksson, Ann-Sofie Rudberg, Cecilia Hellström, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Wanda Christ, Mikaela Olausson, My Hedhammar, Hanna Tegel, Sara Mangsbo, Mia Phillipson, Anna Månberg, Sophia Hober, Peter Nilsson, Charlotte Thålin
medRxiv 2021.01.03.21249162; doi: https://doi.org/10.1101/2021.01.03.21249162
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2880)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12614)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4480)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (909)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4241)
- Nursing (228)
- Nutrition (621)
- Oncology (2225)
- Ophthalmology (632)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6827)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (60)
- Transplantation (204)
- Urology (175)